Radiotherapy, the standard treatment for patients with nasopharyngeal carcinoma (NPC), induces DNA methyltransferase 3B, which greatly contributes to radioresistance in NPC by methylating p53 and p21 [139]. Here, TP53 is linked to nasopharyngeal carcinoma.